Intervention Review

Topotecan for ovarian cancer

  1. Peng Lihua1,
  2. Xiao Y Chen2,
  3. Taixiang Wu3,*

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 23 APR 2008

Assessed as up-to-date: 13 FEB 2008

DOI: 10.1002/14651858.CD005589.pub2


How to Cite

Lihua P, Chen XY, Wu T. Topotecan for ovarian cancer. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD005589. DOI: 10.1002/14651858.CD005589.pub2.

Author Information

  1. 1

    Sichuan University, West China Hospital, Chengdu, Sichuan, China

  2. 2

    The General Hospital of the People's Liberation Army (PLAGH) (also Hospital 301), Department of Neurology, Beijing, Beijing, China

  3. 3

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese EBM Centre, INCLEN Resource and Training Centre, Chengdu, Sichuan, China

*Taixiang Wu, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese EBM Centre, INCLEN Resource and Training Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008

SEARCH